Kathmandu University: Clinical Trials

1 trial sponsored by Kathmandu University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Kathmandu University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Sodium Valproate and Valproic Acid Tablets
Sodium valproate and valproic acid extended release tablet - Epilepsy
Phase 4UnknownKathmandu University162023-08-062023-10-11

Conditions studied

Epilepsy (1)

Interventions

Valproic Acid (1)

Countries

Nepal (1)

Top investigators

Rajani Shakya, PhD (1)

Results publications

PMID 15199078, PMID 15767218, PMID 17472600, PMID 19920901, PMID 8907724